ACET (Adicet Bio, Inc.) Total Enterprise Value
The current market quotes for Adicet Bio (ACET) visualized below demonstrate an enterprise value of -68.46. Adicet Bio generates revenue based on the co-creation of T-cell therapies to combat lymphoma. The business possesses colossal global growth potential due to low per-dose production costs. Furthermore, its operations are completely autonomous from GDP fluctuations, demonstrating absolute resilience to macroeconomic cycles.
Adicet Bio, Inc. (ACET) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Adicet Bio (ACET)
Enterprise value determines the total buyout price of a business by summing market capitalization and net debt. By analyzing the indicative enterprise value level, an investor sees the real scale of assets accounting for liquidity. The metric's dynamics reflect phase shifts in the industry and market expectations. For Adicet Bio (ACET), this indicator confirms capitalization potential driven by its unique allogeneic platform. Inelastic demand for lymphoma therapies provides the company with significant future pricing power.
Competitor analysis for Adicet Bio
Real Price to Acquire Entire Company argenx N.V. ARGX|BNTX (BioNTech Group) - Enterprise Value|Abivax Pharma (ABVX) - Total Enterprise Value|ADMA - Real Price to Acquire Entire Company|PTGX (protagonist-inc.com) - Aggregate Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|enGene Bio - Enterprise Value|RAPT - Enterprise Value|Enterprise Value aerovatetx.com|aclaristx.com (ACRS) - Business Value|KYTX: Enterprise Value|Company Buyout Price Tiziana Life Sciences Ltd.|Enterprise Value CABA (Cabaletta Bio, Inc)|Real Price to Acquire Entire Company Ventyx Biosciences, Inc (VTYX)|THTX: Enterprise Value|AVTX - Total Enterprise Value|Real Price to Acquire Entire Company Eledon Pharmaceuticals, Inc. ELDN|Agenus, Inc. (AGEN) - Aggregate Business Value|Real Price to Acquire Entire Company Climb Bio, Inc. CLYM|Zura Bio Ltd (ZURA) - Value Adjusted for Debt and Cash|Enterprise Value aTyr Pharma, Inc.|Total Company Value Adagene Corp|IMA (ImageneBio Inc) - Enterprise Value|Company Buyout Price STTK (shattucklabs.com)|EQ: Total Company Value|Total Enterprise Value Connect Biopharma Holdings CNTB|Immunic Inc - Enterprise Value|ATRA - Enterprise Value|IFRX (inflarx.de) - Enterprise Value|X4 Pharmaceuticals Inc. (XFOR) - Real Price to Acquire Entire Company|Enterprise Value CELU (Celularity Inc)|Total Enterprise Value INmune Bio Corporation (INMB)|Real Price to Acquire Entire Company Barinthus Biotherapeutics|Aggregate Business Value KZR (kezarlifesciences.com)|SAB Biotherapeutics, Inc. (SABS) - Total Company Value|Full Business Value Akari Therapeutics PLC AKTX|Enterprise Value Enlivex Therapeutics, Ltd. (ENLV)|QTTB - Value Adjusted for Debt and Cash|GOVX: Enterprise Value|EDSA (edesabiotech.com) - Enterprise Value|IBIO - Total Company Value|Value Adjusted for Debt and Cash CARM|Total Company Value XTLB (XTL Biopharmaceuticals, Ltd.)|Real Price to Acquire Entire Company boltbio.com (BOLT)|Enterprise Value HCWB (HCW Biologics)|APVO - Enterprise Value|Real Price to Acquire Entire Company AIM ImmunoTech Inc. (AIM)|ADTX - Value Adjusted for Debt and Cash|GRI Bio Corp - Enterprise Value|XRTX (XORTX Corp) - Company Buyout Price|Total Company Value HIND|Real Price to Acquire Entire Company REVB|Total Company Value INDP (Indaptus Therapeutics, Inc.)|Real Price to Acquire Entire Company Scinai Immunotherapeutics Ltd SCNI|Real Price to Acquire Entire Company CALI (CalciMedica)|Affimed NV - Enterprise Value|Allakos Therapeutics (ALLK) - Total Company Value|HOOK - Business Value|Enterprise Value IGMS|iTeos Therapeutics Inc (ITOS) - Total Enterprise Value|OCEA (Ocean Bio) - Enterprise Value|Enterprise Value TC BioPharm Ltd|Enterprise Value Third Harmonic Bio THRD